CRISPR Therapeutics AG (CRSP) Current Taxes (2016 - 2025)
Historic Current Taxes for CRISPR Therapeutics AG (CRSP) over the last 11 years, with Q4 2025 value amounting to $1.1 million.
- CRISPR Therapeutics AG's Current Taxes rose 14678.49% to $1.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 million, marking a year-over-year increase of 14678.49%. This contributed to the annual value of $1.1 million for FY2025, which is 14678.49% up from last year.
- According to the latest figures from Q4 2025, CRISPR Therapeutics AG's Current Taxes is $1.1 million, which was up 14678.49% from $3.4 million recorded in Q3 2025.
- In the past 5 years, CRISPR Therapeutics AG's Current Taxes ranged from a high of $4.5 million in Q2 2021 and a low of $135000.0 during Q4 2022
- In the last 5 years, CRISPR Therapeutics AG's Current Taxes had a median value of $975500.0 in 2024 and averaged $1.7 million.
- As far as peak fluctuations go, CRISPR Therapeutics AG's Current Taxes skyrocketed by 108169.01% in 2021, and later plummeted by 9588.01% in 2023.
- Over the past 5 years, CRISPR Therapeutics AG's Current Taxes (Quarter) stood at $724000.0 in 2021, then crashed by 81.35% to $135000.0 in 2022, then skyrocketed by 224.44% to $438000.0 in 2023, then increased by 2.97% to $451000.0 in 2024, then skyrocketed by 146.78% to $1.1 million in 2025.
- Its last three reported values are $1.1 million in Q4 2025, $3.4 million for Q3 2025, and $715000.0 during Q2 2025.